Pooja Ghatalia, MD shares new insights from RETAIN trials in MIBCByPooja Ghatalia, MDFebruary 27th 2026Pooja Ghatalia, MD, shares data from an integrated analysis of the RETAIN trials in muscle-invasive bladder cancer.
Pooja Ghatalia, MD, on interim findings from RETAIN-2 trial in MIBCByPooja Ghatalia, MDFebruary 14th 2025"We see that among the patients who went on to receiving cystectomy, 84% are metastases free," says Pooja Ghatalia, MD.